Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-05-20

AUTHORS

K. E. Naylor, R. M. Jacques, M. Paggiosi, F. Gossiel, N. F. A. Peel, E. V. McCloskey, J. S. Walsh, R. Eastell

ABSTRACT

We used bone turnover markers to identify women who responded to bisphosphonate treatment for osteoporosis. Response was more likely with alendronate and ibandronate than risedronate. There was a greater decrease in bone markers if baseline bone turnover markers were higher and if the patient took more than 80 % of her medication.IntroductionBiochemical response to bisphosphonate therapy can be assessed using either a decrease in bone turnover marker beyond the least significant change (LSC) or a reduction to within a reference interval (RI). We compared the performance of these target responses and determined whether response was related to the type of bisphosphonate, compliance and baseline bone turnover markers.MethodsBiochemical responses to three oral bisphosphonates were assessed in an open, controlled trial comprising 172 postmenopausal osteoporotic women (age 53–84 years), randomised to alendronate, ibandronate or risedronate, plus calcium and vitamin D supplementation for 2 years. The LSC for each marker was derived within the study population, whereas RIs were obtained from a control group of healthy premenopausal women (age 35–40 years).ResultsOver 70 % of women achieved a target response for serum CTX and PINP, irrespective of the approach used. The percentage decrease at 12 weeks was greater for women with baseline PINP above the RI −63 % (difference 13 %, 95 % CI 0 to 27.1, P = 0.049) and good compliance −67 % (difference 15.9 %, 95 % CI 6.3 to 25.5, P = 0.001). Responders had a greater increase in spine bone density compared to nonresponders; for example 6.2 vs. 2.3 % (difference 3.9 %, 95 % CI 1.6 to 6.3, P = 0.0011) for PINP LSC. The magnitude of change in bone markers was greater with ibandronate and alendronate than risedronate.ConclusionsBoth approaches to response identified similar proportions of women as responders. Nonresponders had smaller increases in BMD, and we suggest that biochemical assessment of response is a useful tool for the management of women with postmenopausal osteoporosis. More... »

PAGES

21-31

References to SciGraph publications

  • 2000-12. Preanalytical Variability of Biochemical Markers of Bone Turnover in OSTEOPOROSIS INTERNATIONAL
  • 2000-01. Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2000-05. Differences in the Capacity of Several Biochemical Bone Markers to Assess High Bone Turnover in Early Menopause and Response to Alendronate Therapy in OSTEOPOROSIS INTERNATIONAL
  • 2010-12-24. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards in OSTEOPOROSIS INTERNATIONAL
  • 2013-05-22. Adherence to raloxifene therapy: assessment methods and relationship with efficacy in OSTEOPOROSIS INTERNATIONAL
  • 2012-06-05. Bone turnover markers: use in osteoporosis in NATURE REVIEWS RHEUMATOLOGY
  • 1999-10. Changes in Bone Mass and Bone Turnover Following Ankle Fracture in OSTEOPOROSIS INTERNATIONAL
  • 2005-04. Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data in AGING CLINICAL AND EXPERIMENTAL RESEARCH
  • 2012-08-08. Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice in OSTEOPOROSIS INTERNATIONAL
  • 2008-01-24. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy in OSTEOPOROSIS INTERNATIONAL
  • 2004-05-27. The impact of compliance with osteoporosis therapy on fracture rates in actual practice in OSTEOPOROSIS INTERNATIONAL
  • 2014-07-30. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study in OSTEOPOROSIS INTERNATIONAL
  • 2012-07-27. Treatment failure in osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00198-015-3145-7

    DOI

    http://dx.doi.org/10.1007/s00198-015-3145-7

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1038798784

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/25990354


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Administration, Oral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Alendronate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Density", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Density Conservation Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Remodeling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Diphosphonates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ibandronic Acid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lumbar Vertebrae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis, Postmenopausal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Premenopause", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reference Values", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risedronic Acid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Naylor", 
            "givenName": "K. E.", 
            "id": "sg:person.01046775141.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046775141.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "School of Health and Related Research, University of Sheffield, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "School of Health and Related Research, University of Sheffield, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jacques", 
            "givenName": "R. M.", 
            "id": "sg:person.0661004305.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661004305.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paggiosi", 
            "givenName": "M.", 
            "id": "sg:person.01145737717.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145737717.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gossiel", 
            "givenName": "F.", 
            "id": "sg:person.01171535272.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171535272.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.412937.a", 
              "name": [
                "Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Peel", 
            "givenName": "N. F. A.", 
            "id": "sg:person.012400076124.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012400076124.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McCloskey", 
            "givenName": "E. V.", 
            "id": "sg:person.0766756074.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766756074.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Walsh", 
            "givenName": "J. S.", 
            "id": "sg:person.01077624517.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077624517.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Eastell", 
            "givenName": "R.", 
            "id": "sg:person.0100521534.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100521534.43"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s001980050010", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005303812", 
              "https://doi.org/10.1007/s001980050010"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980070004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022005652", 
              "https://doi.org/10.1007/s001980070004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980050247", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018367575", 
              "https://doi.org/10.1007/s001980050247"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-012-2097-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049047391", 
              "https://doi.org/10.1007/s00198-012-2097-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-007-0540-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051377661", 
              "https://doi.org/10.1007/s00198-007-0540-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-012-2093-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010937754", 
              "https://doi.org/10.1007/s00198-012-2093-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1652-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023624379", 
              "https://doi.org/10.1007/s00198-004-1652-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrrheum.2012.86", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015580657", 
              "https://doi.org/10.1038/nrrheum.2012.86"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-010-1501-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044145841", 
              "https://doi.org/10.1007/s00198-010-1501-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-014-2817-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046047996", 
              "https://doi.org/10.1007/s00198-014-2817-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00004183", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015348029", 
              "https://doi.org/10.1007/pl00004183"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03324588", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050704559", 
              "https://doi.org/10.1007/bf03324588"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-013-2386-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005491554", 
              "https://doi.org/10.1007/s00198-013-2386-6"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2015-05-20", 
        "datePublishedReg": "2015-05-20", 
        "description": "We used bone turnover markers to identify women who responded to bisphosphonate treatment for osteoporosis. Response was more likely with alendronate and ibandronate than risedronate. There was a greater decrease in bone markers if baseline bone turnover markers were higher and if the patient took more than 80\u00a0% of her medication.IntroductionBiochemical response to bisphosphonate therapy can be assessed using either a decrease in bone turnover marker beyond the least significant change (LSC) or a reduction to within a reference interval (RI). We compared the performance of these target responses and determined whether response was related to the type of bisphosphonate, compliance and baseline bone turnover markers.MethodsBiochemical responses to three oral bisphosphonates were assessed in an open, controlled trial comprising 172 postmenopausal osteoporotic women (age 53\u201384\u00a0years), randomised to alendronate, ibandronate or risedronate, plus calcium and vitamin D supplementation for 2\u00a0years. The LSC for each marker was derived within the study population, whereas RIs were obtained from a control group of healthy premenopausal women (age 35\u201340\u00a0years).ResultsOver 70\u00a0% of women achieved a target response for serum CTX and PINP, irrespective of the approach used. The percentage decrease at 12\u00a0weeks was greater for women with baseline PINP above the RI \u221263\u00a0% (difference 13\u00a0%, 95\u00a0% CI 0 to 27.1, P\u2009=\u20090.049) and good compliance \u221267\u00a0% (difference 15.9\u00a0%, 95\u00a0% CI 6.3 to 25.5, P\u2009=\u20090.001). Responders had a greater increase in spine bone density compared to nonresponders; for example 6.2 vs. 2.3\u00a0% (difference 3.9\u00a0%, 95\u00a0% CI 1.6 to 6.3, P\u2009=\u20090.0011) for PINP LSC. The magnitude of change in bone markers was greater with ibandronate and alendronate than risedronate.ConclusionsBoth approaches to response identified similar proportions of women as responders. Nonresponders had smaller increases in BMD, and we suggest that biochemical assessment of response is a useful tool for the management of women with postmenopausal osteoporosis.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00198-015-3145-7", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2770073", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1100834", 
            "issn": [
              "0937-941X", 
              "1433-2965"
            ], 
            "name": "Osteoporosis International", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "27"
          }
        ], 
        "keywords": [
          "bone turnover markers", 
          "baseline bone turnover markers", 
          "least significant change", 
          "turnover markers", 
          "postmenopausal osteoporosis", 
          "reference intervals", 
          "bone markers", 
          "vitamin D supplementation", 
          "oral bisphosphonate therapy", 
          "spine bone density", 
          "postmenopausal osteoporotic women", 
          "healthy premenopausal women", 
          "management of women", 
          "type of bisphosphonate", 
          "oral bisphosphonates", 
          "D supplementation", 
          "bisphosphonate therapy", 
          "premenopausal women", 
          "serum CTX", 
          "osteoporotic women", 
          "study population", 
          "bone density", 
          "biochemical assessment", 
          "ResultsOver 70", 
          "control group", 
          "good compliance", 
          "osteoporosis", 
          "risedronate", 
          "women", 
          "greater decrease", 
          "similar proportions", 
          "percentage decrease", 
          "nonresponders", 
          "PINP", 
          "bisphosphonates", 
          "therapy", 
          "markers", 
          "greater increase", 
          "magnitude of change", 
          "responders", 
          "trio studies", 
          "significant changes", 
          "small increase", 
          "response", 
          "medications", 
          "patients", 
          "alendronate", 
          "compliance", 
          "BMD", 
          "decrease", 
          "CTX", 
          "trials", 
          "supplementation", 
          "weeks", 
          "ConclusionsBoth", 
          "useful tool", 
          "treatment", 
          "calcium", 
          "increase", 
          "group", 
          "changes", 
          "population", 
          "years", 
          "proportion", 
          "target response", 
          "interval", 
          "assessment", 
          "management", 
          "study", 
          "reduction", 
          "types", 
          "tool", 
          "magnitude", 
          "approach", 
          "density", 
          "performance"
        ], 
        "name": "Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study", 
        "pagination": "21-31", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1038798784"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00198-015-3145-7"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "25990354"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00198-015-3145-7", 
          "https://app.dimensions.ai/details/publication/pub.1038798784"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:59", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_658.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00198-015-3145-7"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-015-3145-7'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-015-3145-7'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-015-3145-7'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-015-3145-7'


     

    This table displays all metadata directly associated to this object as RDF triples.

    325 TRIPLES      21 PREDICATES      134 URIs      113 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00198-015-3145-7 schema:about N09c3e8b4da8f4951ad5533f1ebedda1c
    2 N184b412572c645bc9958871a2b7e410f
    3 N28ce4c7ba5434b7a9fa5e7a2a43b8702
    4 N3480d4df9c094effa41daaeea329f379
    5 N370dbc710cef4c0cbf50af6e9ca04022
    6 N498040b9f1e94db4975ba66773e6efcb
    7 N78f71348e9434d6f9f2265ab0b38d5a0
    8 N7c4f2d93f45e463dbcd34b3a92782c48
    9 N823ac828370e45aa979b4f92ee3e0cc6
    10 N87e5430e45af498d83ce31abb04f0ed3
    11 N905f7ecd231e459cbd86eb6ac1bd7514
    12 N9239da13176c477e91303edf07bc23d5
    13 N93bd87f8e37245d3bd3ac15208453521
    14 N9c7c0efa61a54d7699aa4c368463a82c
    15 Naa27cb34a4cd4f5289579e84b0729019
    16 Nc4bc0ef8a4d94072836877ff34578378
    17 Nd01a60c2c1bd4c5688b575cc3cf9df14
    18 Nd800c843bccd4d9ea6b33000b98c7daa
    19 Ne38eb74c6391403c8a106f2e05bc33bf
    20 Nf23164a34b354dbfb7435af23a5c94ef
    21 anzsrc-for:11
    22 anzsrc-for:1103
    23 schema:author N94d9af7d927d4324aecf080124c35c7b
    24 schema:citation sg:pub.10.1007/bf03324588
    25 sg:pub.10.1007/pl00004183
    26 sg:pub.10.1007/s00198-004-1652-z
    27 sg:pub.10.1007/s00198-007-0540-8
    28 sg:pub.10.1007/s00198-010-1501-1
    29 sg:pub.10.1007/s00198-012-2093-8
    30 sg:pub.10.1007/s00198-012-2097-4
    31 sg:pub.10.1007/s00198-013-2386-6
    32 sg:pub.10.1007/s00198-014-2817-z
    33 sg:pub.10.1007/s001980050010
    34 sg:pub.10.1007/s001980050247
    35 sg:pub.10.1007/s001980070004
    36 sg:pub.10.1038/nrrheum.2012.86
    37 schema:datePublished 2015-05-20
    38 schema:datePublishedReg 2015-05-20
    39 schema:description We used bone turnover markers to identify women who responded to bisphosphonate treatment for osteoporosis. Response was more likely with alendronate and ibandronate than risedronate. There was a greater decrease in bone markers if baseline bone turnover markers were higher and if the patient took more than 80 % of her medication.IntroductionBiochemical response to bisphosphonate therapy can be assessed using either a decrease in bone turnover marker beyond the least significant change (LSC) or a reduction to within a reference interval (RI). We compared the performance of these target responses and determined whether response was related to the type of bisphosphonate, compliance and baseline bone turnover markers.MethodsBiochemical responses to three oral bisphosphonates were assessed in an open, controlled trial comprising 172 postmenopausal osteoporotic women (age 53–84 years), randomised to alendronate, ibandronate or risedronate, plus calcium and vitamin D supplementation for 2 years. The LSC for each marker was derived within the study population, whereas RIs were obtained from a control group of healthy premenopausal women (age 35–40 years).ResultsOver 70 % of women achieved a target response for serum CTX and PINP, irrespective of the approach used. The percentage decrease at 12 weeks was greater for women with baseline PINP above the RI −63 % (difference 13 %, 95 % CI 0 to 27.1, P = 0.049) and good compliance −67 % (difference 15.9 %, 95 % CI 6.3 to 25.5, P = 0.001). Responders had a greater increase in spine bone density compared to nonresponders; for example 6.2 vs. 2.3 % (difference 3.9 %, 95 % CI 1.6 to 6.3, P = 0.0011) for PINP LSC. The magnitude of change in bone markers was greater with ibandronate and alendronate than risedronate.ConclusionsBoth approaches to response identified similar proportions of women as responders. Nonresponders had smaller increases in BMD, and we suggest that biochemical assessment of response is a useful tool for the management of women with postmenopausal osteoporosis.
    40 schema:genre article
    41 schema:isAccessibleForFree true
    42 schema:isPartOf Nd917dec976a14f1e8bf50f646d10089f
    43 Ne0292d0b4a11449e920fd83475401065
    44 sg:journal.1100834
    45 schema:keywords BMD
    46 CTX
    47 ConclusionsBoth
    48 D supplementation
    49 PINP
    50 ResultsOver 70
    51 alendronate
    52 approach
    53 assessment
    54 baseline bone turnover markers
    55 biochemical assessment
    56 bisphosphonate therapy
    57 bisphosphonates
    58 bone density
    59 bone markers
    60 bone turnover markers
    61 calcium
    62 changes
    63 compliance
    64 control group
    65 decrease
    66 density
    67 good compliance
    68 greater decrease
    69 greater increase
    70 group
    71 healthy premenopausal women
    72 increase
    73 interval
    74 least significant change
    75 magnitude
    76 magnitude of change
    77 management
    78 management of women
    79 markers
    80 medications
    81 nonresponders
    82 oral bisphosphonate therapy
    83 oral bisphosphonates
    84 osteoporosis
    85 osteoporotic women
    86 patients
    87 percentage decrease
    88 performance
    89 population
    90 postmenopausal osteoporosis
    91 postmenopausal osteoporotic women
    92 premenopausal women
    93 proportion
    94 reduction
    95 reference intervals
    96 responders
    97 response
    98 risedronate
    99 serum CTX
    100 significant changes
    101 similar proportions
    102 small increase
    103 spine bone density
    104 study
    105 study population
    106 supplementation
    107 target response
    108 therapy
    109 tool
    110 treatment
    111 trials
    112 trio studies
    113 turnover markers
    114 type of bisphosphonate
    115 types
    116 useful tool
    117 vitamin D supplementation
    118 weeks
    119 women
    120 years
    121 schema:name Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
    122 schema:pagination 21-31
    123 schema:productId N290e87067e3f40058c0dc6c918a16188
    124 Nae3f0c01f6a043d5b123ae1d51509d12
    125 Nce47a138167647e6b7ef161f15a1fb35
    126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038798784
    127 https://doi.org/10.1007/s00198-015-3145-7
    128 schema:sdDatePublished 2022-11-24T20:59
    129 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    130 schema:sdPublisher N2df1f3786528460c9646577d99c96359
    131 schema:url https://doi.org/10.1007/s00198-015-3145-7
    132 sgo:license sg:explorer/license/
    133 sgo:sdDataset articles
    134 rdf:type schema:ScholarlyArticle
    135 N08fc5ee1d67e483dadf54ff0a73c2d6b rdf:first sg:person.01171535272.49
    136 rdf:rest Ne2caa4e162bc47dca3ed5ebcd472149a
    137 N09c3e8b4da8f4951ad5533f1ebedda1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Female
    139 rdf:type schema:DefinedTerm
    140 N184b412572c645bc9958871a2b7e410f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Bone Remodeling
    142 rdf:type schema:DefinedTerm
    143 N28ce4c7ba5434b7a9fa5e7a2a43b8702 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Aged, 80 and over
    145 rdf:type schema:DefinedTerm
    146 N290e87067e3f40058c0dc6c918a16188 schema:name pubmed_id
    147 schema:value 25990354
    148 rdf:type schema:PropertyValue
    149 N2df1f3786528460c9646577d99c96359 schema:name Springer Nature - SN SciGraph project
    150 rdf:type schema:Organization
    151 N3480d4df9c094effa41daaeea329f379 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Ibandronic Acid
    153 rdf:type schema:DefinedTerm
    154 N370dbc710cef4c0cbf50af6e9ca04022 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Risedronic Acid
    156 rdf:type schema:DefinedTerm
    157 N48fcc3c7fc17457897c4857d4ddeed51 rdf:first sg:person.0100521534.43
    158 rdf:rest rdf:nil
    159 N498040b9f1e94db4975ba66773e6efcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Humans
    161 rdf:type schema:DefinedTerm
    162 N5949321b954f4607a1769096d7feddf6 rdf:first sg:person.0661004305.45
    163 rdf:rest N5c48cb0441224fca8527adf348eeb611
    164 N5c48cb0441224fca8527adf348eeb611 rdf:first sg:person.01145737717.60
    165 rdf:rest N08fc5ee1d67e483dadf54ff0a73c2d6b
    166 N78f71348e9434d6f9f2265ab0b38d5a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Bone Density Conservation Agents
    168 rdf:type schema:DefinedTerm
    169 N7c4f2d93f45e463dbcd34b3a92782c48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Reference Values
    171 rdf:type schema:DefinedTerm
    172 N823ac828370e45aa979b4f92ee3e0cc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Aged
    174 rdf:type schema:DefinedTerm
    175 N87e5430e45af498d83ce31abb04f0ed3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Bone Density
    177 rdf:type schema:DefinedTerm
    178 N905f7ecd231e459cbd86eb6ac1bd7514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Alendronate
    180 rdf:type schema:DefinedTerm
    181 N9239da13176c477e91303edf07bc23d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Osteoporosis, Postmenopausal
    183 rdf:type schema:DefinedTerm
    184 N93bd87f8e37245d3bd3ac15208453521 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Adult
    186 rdf:type schema:DefinedTerm
    187 N94d9af7d927d4324aecf080124c35c7b rdf:first sg:person.01046775141.46
    188 rdf:rest N5949321b954f4607a1769096d7feddf6
    189 N9c7c0efa61a54d7699aa4c368463a82c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Premenopause
    191 rdf:type schema:DefinedTerm
    192 Na9f594a1938d449ba6b1456cb7786cb5 rdf:first sg:person.0766756074.39
    193 rdf:rest Nd49236dcb0e7423e94fb439a01c82062
    194 Naa27cb34a4cd4f5289579e84b0729019 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Lumbar Vertebrae
    196 rdf:type schema:DefinedTerm
    197 Nae3f0c01f6a043d5b123ae1d51509d12 schema:name doi
    198 schema:value 10.1007/s00198-015-3145-7
    199 rdf:type schema:PropertyValue
    200 Nc4bc0ef8a4d94072836877ff34578378 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Administration, Oral
    202 rdf:type schema:DefinedTerm
    203 Nce47a138167647e6b7ef161f15a1fb35 schema:name dimensions_id
    204 schema:value pub.1038798784
    205 rdf:type schema:PropertyValue
    206 Nd01a60c2c1bd4c5688b575cc3cf9df14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Diphosphonates
    208 rdf:type schema:DefinedTerm
    209 Nd49236dcb0e7423e94fb439a01c82062 rdf:first sg:person.01077624517.19
    210 rdf:rest N48fcc3c7fc17457897c4857d4ddeed51
    211 Nd800c843bccd4d9ea6b33000b98c7daa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Middle Aged
    213 rdf:type schema:DefinedTerm
    214 Nd917dec976a14f1e8bf50f646d10089f schema:issueNumber 1
    215 rdf:type schema:PublicationIssue
    216 Ne0292d0b4a11449e920fd83475401065 schema:volumeNumber 27
    217 rdf:type schema:PublicationVolume
    218 Ne2caa4e162bc47dca3ed5ebcd472149a rdf:first sg:person.012400076124.59
    219 rdf:rest Na9f594a1938d449ba6b1456cb7786cb5
    220 Ne38eb74c6391403c8a106f2e05bc33bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name Treatment Outcome
    222 rdf:type schema:DefinedTerm
    223 Nf23164a34b354dbfb7435af23a5c94ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    224 schema:name Biomarkers
    225 rdf:type schema:DefinedTerm
    226 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    227 schema:name Medical and Health Sciences
    228 rdf:type schema:DefinedTerm
    229 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    230 schema:name Clinical Sciences
    231 rdf:type schema:DefinedTerm
    232 sg:grant.2770073 http://pending.schema.org/fundedItem sg:pub.10.1007/s00198-015-3145-7
    233 rdf:type schema:MonetaryGrant
    234 sg:journal.1100834 schema:issn 0937-941X
    235 1433-2965
    236 schema:name Osteoporosis International
    237 schema:publisher Springer Nature
    238 rdf:type schema:Periodical
    239 sg:person.0100521534.43 schema:affiliation grid-institutes:grid.11835.3e
    240 schema:familyName Eastell
    241 schema:givenName R.
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100521534.43
    243 rdf:type schema:Person
    244 sg:person.01046775141.46 schema:affiliation grid-institutes:grid.11835.3e
    245 schema:familyName Naylor
    246 schema:givenName K. E.
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046775141.46
    248 rdf:type schema:Person
    249 sg:person.01077624517.19 schema:affiliation grid-institutes:grid.11835.3e
    250 schema:familyName Walsh
    251 schema:givenName J. S.
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077624517.19
    253 rdf:type schema:Person
    254 sg:person.01145737717.60 schema:affiliation grid-institutes:grid.11835.3e
    255 schema:familyName Paggiosi
    256 schema:givenName M.
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145737717.60
    258 rdf:type schema:Person
    259 sg:person.01171535272.49 schema:affiliation grid-institutes:grid.11835.3e
    260 schema:familyName Gossiel
    261 schema:givenName F.
    262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171535272.49
    263 rdf:type schema:Person
    264 sg:person.012400076124.59 schema:affiliation grid-institutes:grid.412937.a
    265 schema:familyName Peel
    266 schema:givenName N. F. A.
    267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012400076124.59
    268 rdf:type schema:Person
    269 sg:person.0661004305.45 schema:affiliation grid-institutes:grid.11835.3e
    270 schema:familyName Jacques
    271 schema:givenName R. M.
    272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661004305.45
    273 rdf:type schema:Person
    274 sg:person.0766756074.39 schema:affiliation grid-institutes:grid.11835.3e
    275 schema:familyName McCloskey
    276 schema:givenName E. V.
    277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766756074.39
    278 rdf:type schema:Person
    279 sg:pub.10.1007/bf03324588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050704559
    280 https://doi.org/10.1007/bf03324588
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1007/pl00004183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015348029
    283 https://doi.org/10.1007/pl00004183
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1007/s00198-004-1652-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1023624379
    286 https://doi.org/10.1007/s00198-004-1652-z
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1007/s00198-007-0540-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051377661
    289 https://doi.org/10.1007/s00198-007-0540-8
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1007/s00198-010-1501-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044145841
    292 https://doi.org/10.1007/s00198-010-1501-1
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.1007/s00198-012-2093-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010937754
    295 https://doi.org/10.1007/s00198-012-2093-8
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1007/s00198-012-2097-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049047391
    298 https://doi.org/10.1007/s00198-012-2097-4
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1007/s00198-013-2386-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005491554
    301 https://doi.org/10.1007/s00198-013-2386-6
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1007/s00198-014-2817-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1046047996
    304 https://doi.org/10.1007/s00198-014-2817-z
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1007/s001980050010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005303812
    307 https://doi.org/10.1007/s001980050010
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1007/s001980050247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018367575
    310 https://doi.org/10.1007/s001980050247
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1007/s001980070004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022005652
    313 https://doi.org/10.1007/s001980070004
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/nrrheum.2012.86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015580657
    316 https://doi.org/10.1038/nrrheum.2012.86
    317 rdf:type schema:CreativeWork
    318 grid-institutes:grid.11835.3e schema:alternateName Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK
    319 School of Health and Related Research, University of Sheffield, Sheffield, UK
    320 schema:name Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research, University of Sheffield, Herries Road, S5 7AU, Sheffield, South Yorkshire, UK
    321 School of Health and Related Research, University of Sheffield, Sheffield, UK
    322 rdf:type schema:Organization
    323 grid-institutes:grid.412937.a schema:alternateName Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK
    324 schema:name Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK
    325 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...